MEDCLUERX Trademark

Trademark Overview

On Friday, November 4, 2016, a trademark application was filed for MEDCLUERX with the United States Patent and Trademark Office. The USPTO has given the MEDCLUERX trademark a serial number of 87227366. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, February 16, 2024. This trademark is owned by NorthShore University HealthSystem. The MEDCLUERX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing scientific analysis and informational reports in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases; reporting services based upon the results of laboratory testing in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases
medcluerx

General Information

Serial Number87227366
Word MarkMEDCLUERX
Filing DateFriday, November 4, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, February 16, 2024
Registration Number5308238
Registration DateTuesday, October 10, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the words "MEDCLUE" and a superscript "RX" and three circles located below the superscript "RX".
Goods and ServicesProviding scientific analysis and informational reports in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases; reporting services based upon the results of laboratory testing in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases
NOT AVAILABLE"RX"
Pseudo MarkMED CLUE RX

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 9, 2016
Primary Code042
First Use Anywhere DateThursday, January 12, 2017
First Use In Commerce DateThursday, January 12, 2017

Trademark Owner History

Party NameNorthShore University HealthSystem
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressWarrenville, IL 60555
US
Party NameNorthShore University HealthSystem
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEvanston, IL 60201
US
Party NameNorthShore University HealthSystem
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEvanston, IL 60201
US

Trademark Events

Event DateEvent Description
Tuesday, November 8, 2016NEW APPLICATION ENTERED
Wednesday, November 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 10, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 8, 2016ASSIGNED TO EXAMINER
Wednesday, December 14, 2016NON-FINAL ACTION WRITTEN
Wednesday, December 14, 2016NON-FINAL ACTION E-MAILED
Wednesday, December 14, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 31, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, August 22, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 31, 2017USE AMENDMENT FILED
Thursday, August 24, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 7, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 8, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 10, 2017REGISTERED-PRINCIPAL REGISTER
Monday, April 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 2, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 10, 2018REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Monday, April 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 10, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 29, 2023TEAS SECTION 8 & 15 RECEIVED
Friday, February 16, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 16, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 16, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, February 20, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 20, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 20, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 20, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 20, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

medcluerx testing genetic analytics phenotyping pharmacogenomics assessing diseases certain associated risks